News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks

No Picture
News

Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B

January 7, 2026 SDBN Comments Off on Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced positive results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the safety and efficacy of bepirovirsen, an investigational antisense oligonucleotide […]

News

Novoron Bioscience Awarded $2.5 Million NIH/NIA SBIR Grant to Accelerate Alzheimer’s Drug Discovery with Human Brain Organoids

January 6, 2026 SDBN Comments Off on Novoron Bioscience Awarded $2.5 Million NIH/NIA SBIR Grant to Accelerate Alzheimer’s Drug Discovery with Human Brain Organoids

SAN DIEGO, Jan. 6, 2026 /PRNewswire/ — Novoron Bioscience, a San Diego-based biotechnology company developing therapies for neurodegenerative diseases and neurological injury, has received a $2.5 million Small Business Innovation Research (SBIR) grant from the […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

2026 New Year’s Greetings from the CEO

January 6, 2026 SDBN Comments Off on 2026 New Year’s Greetings from the CEO

LA JOLLA, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) provides shareholders a corporate […]

No Picture
News

Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology

January 6, 2026 SDBN Comments Off on Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology

SAN DIEGO & BOSTON & BILBAO, Spain–(BUSINESS WIRE)–Artis BioSolutions (“Artis”), a San Diego-based advanced-therapies development and manufacturing company, today announced that it has entered into a definitive agreement to acquire Syngoi Technologies (“Syngoi”), a Spanish […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience

January 6, 2026 SDBN Comments Off on Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell therapies for serious medical conditions, today announced the receipt of […]

News

Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity

January 5, 2026 SDBN Comments Off on Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity

Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) and Skye Bioscience, Inc. (Nasdaq: SKYE) today announced the companies entered […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

December 31, 2025 SDBN Comments Off on BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

SAN DIEGO, Dec. 31, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, and […]

News

HAI Solutions Receives FDA De Novo Grant for QIKCAP System: Pioneering UVC Technology for Microbial Reduction on Needleless IV Connectors

December 30, 2025 SDBN Comments Off on HAI Solutions Receives FDA De Novo Grant for QIKCAP System: Pioneering UVC Technology for Microbial Reduction on Needleless IV Connectors

CARLSBAD, Calif., Dec. 30, 2025 /PRNewswire/ — HAI Solutions, a leading innovator in ultraviolet (UVC) microbial reduction medical devices, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo classification for […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Sinopia Biosciences Awarded NIGMS Grant to Advance LEADS® Platform for Data-Driven Drug Discovery

December 30, 2025 SDBN Comments Off on Sinopia Biosciences Awarded NIGMS Grant to Advance LEADS® Platform for Data-Driven Drug Discovery

SAN DIEGO–(BUSINESS WIRE)–Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® drug discovery platform, announced today it has been awarded a research grant from the National Institute of General Medical […]

No Picture
News

Health Net Providing Special Assistance to Members Affected by the Atmospheric Rivers Due to the “2025 Late December Storms” in Los Angeles, Orange, Riverside, San Bernardino, San Diego, and Shasta Counties

December 29, 2025 SDBN Comments Off on Health Net Providing Special Assistance to Members Affected by the Atmospheric Rivers Due to the “2025 Late December Storms” in Los Angeles, Orange, Riverside, San Bernardino, San Diego, and Shasta Counties

Health Net Assisting Members During State of Emergency SACRAMENTO, Calif., Dec. 29, 2025 /PRNewswire/ — In response to Gov. Gavin Newsom’s declared state of emergency in Los Angeles, Orange, Riverside, San Bernardino, San Diego, and […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC “Blockbuster” Therapy

December 28, 2025 SDBN Comments Off on Senhwa Biosciences Aims at Multi-Billion Dollar Global Market with CX-5461 Combined with ADC “Blockbuster” Therapy

TAIPEI and SAN DIEGO, Dec. 28, 2025 /PRNewswire/ — Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging field of […]

No Picture
News

Singlera Genomics Signs European Distribution and Research Agreement with Pure Medical for Cancer Detection Products

December 23, 2025 SDBN Comments Off on Singlera Genomics Signs European Distribution and Research Agreement with Pure Medical for Cancer Detection Products

LA JOLLA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) — Singlera Genomics, a company focused on the development and application of novel DNA methylation technologies to genetic diagnosis, today announced that it has entered into a […]

No Picture
News

BioMed Realty’s Sustainability Report Emphasizes Long-Term Commitment to Sustainable, Innovative Environments as Recognized by GRESB

December 23, 2025 SDBN Comments Off on BioMed Realty’s Sustainability Report Emphasizes Long-Term Commitment to Sustainable, Innovative Environments as Recognized by GRESB

SAN DIEGO–(BUSINESS WIRE)–BioMed Realty (“Company”), the largest privately owned operator of real estate for the life science and technology industries in the United States and the United Kingdom, today released its 2024 Sustainability Report, demonstrating […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Seven Biopharma Trends to Watch in 2026

December 23, 2025 SDBN Comments Off on Seven Biopharma Trends to Watch in 2026

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last spring. […]

No Picture
News

Robles BioCeutics Publishes in Top-Tiered Peer-Reviewed Medical Journal the Scientific Basis for its Novel Age Reversing Skin Care Products

December 23, 2025 SDBN Comments Off on Robles BioCeutics Publishes in Top-Tiered Peer-Reviewed Medical Journal the Scientific Basis for its Novel Age Reversing Skin Care Products

Novel Way of Skin “Time Reversal” Involves Activating Existing Stem Cells in Skin SAN DIEGO, Calif., Dec. 23, 2025 /PRNewswire/ — Robles BioCeutics, a regenerative dermatology company translating senolytic science and stem cell inspired discovery […]

No Picture
News

Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference

December 23, 2025 SDBN Comments Off on Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference

TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined continued progress […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology

December 22, 2025 SDBN Comments Off on Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology

SAN DIEGO–(BUSINESS WIRE)–Vividion announces publication on discovery and preclinical study of small molecules activating KEAP1 via a covalent molecular glue to degrade NRF2. Click here to view original post Click Here to Publish/Feature Your Company […]


ADVERTISEMENT — Advertise With Biotech Networks
News

PMB Project, Abrazo Health Litchfield Medical Building, Named 2025 HREI Insights™ Award Finalist

December 18, 2025 SDBN Comments Off on PMB Project, Abrazo Health Litchfield Medical Building, Named 2025 HREI Insights™ Award Finalist

Healthcare Real Estate Insights™ magazine’s national awards program honors PMB’s Abrazo Health Litchfield Medical Building, the first combination medical office and inpatient rehabilitation facility in Goodyear, Ariz. SAN DIEGO, Dec. 18, 2025 /PRNewswire/ — PMB’s […]